Skip to Content

GX EJ7 (Epivir 300 mg)

Generic Name: lamivudine

Pill with imprint GX EJ7 is Gray, Four-sided and has been identified as Epivir 300 mg. It is supplied by GlaxoSmithKline.

Epivir is used in the treatment of hepatitis b; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GX EJ7

Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7  Front
Epivir 300 mg GX EJ7  Back
Epivir 300 mg GX EJ7

Epivir

Generic Name:
lamivudine
Imprint:
GX EJ7
Strength:
300 mg
Color:
Gray
Size:
17.00 mm
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
ferric oxide black
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide